Working to Address the FDA Critical Path Opportunity for Generic Nasal Spray Suspensions
[fa icon="calendar'] Jan 22, 2013 3:27:15 PM / by Admin posted in bioequivalence, Blog, cGMP laboratory, Critical Path Opportunity, Generic nasal spray suspsension, Ingredient-Specific Particle Sizsing, Pharmaceutical, Pharmaceutical Webinars, Raman chemical imaging, Recorded Webinars